D Dressler. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anti-Dyskinesia Agents/immunologyAnti-Dyskinesia Agents/therapeutic useAntibody FormationBlepharospasm/drug therapyBotulinum Toxins/immunologyBotulinum Toxins/therapeutic useDisease ProgressionFemaleHumansMiddle AgedTreatment Outcome
Substances: See more » Anti-Dyskinesia AgentsBotulinum Toxins
Year: 2000 PMID: 11127541 DOI: 10.1007/s004150070100
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849